About this episode
Both the S&P 500 and the Nasdaq Composite ended Monday's trading session lower as chip stocks faltered, while the Dow Jones gained 0.25% on the day. It was a similar story in Asia this morning as investors digested the potential ramifications of 'Operation Economic Outcast', while awaiting not only Nvidia's and Marvell Technology's results and US PCE data tomorrow, but also a highly anticipated speech by Kevin Warsh at Jackson Hole this Friday.
Damien Ng, Next Generation Research, joins the podcast today to provide his take on the good news last week from the Moderna/Merck cancer trials. Tune in to the podcast to find out why he believes that innovation-driven healthcare remains one of the most compelling long-term investment opportunities.
- (00:00) - Introduction: Lucija Caculovic, Product & Investment Content
- (00:41) - Markets wrap-up: Bernadette Anderko, Product & Investment Content
- (07:07) - How personalised vaccines could transform cancer treatment: Damien Ng, Next Generation Research
- (12:23) - Closing remarks: Lucija Caculovic, Product & Investment Content
Would you like to support this show? Please leave us a review and star rating on Apple Podcasts, Spotify or wherever you get your podcasts.
Get every episode summarized
Each time Moving Markets publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.
Email me new episodesFree for 3 shows. No card needed.
Hosts & guests
No transcript yet
This episode has not been transcribed. Request it and it moves to the front of the queue.
More episodes
More from Moving Markets
The View Beyond: Market Outlook Year-End 2026 – US headlines, global opportuniti...
Moving Markets
A hawkish ECB and 10-year US Treasury yield near 5%
Moving Markets
Oil surges, yields spike and central banks take centre stage
Moving Markets
Oil rally fuels inflation concerns
Moving Markets